Citations (113)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Sunita , Yogendra Singh, Gillian Beamer, Xingmin Sun & Pratyoosh Shukla. (2022) Recent developments in systems biology and genetic engineering toward design of vaccines for TB. Critical Reviews in Biotechnology 42:4, pages 532-547.
Read now
Read now
Jonathan G. Pol, Sergio A. Acuna, Beta Yadollahi, Nan Tang, Kyle B. Stephenson, Matthew J. Atherton, David Hanwell, Alexander El-Warrak, Alyssa Goldstein, Badru Moloo, Patricia V. Turner, Roberto Lopez, Sandra LaFrance, Carole Evelegh, Galina Denisova, Robin Parsons, Jamie Millar, Gautier Stoll, Chantal G. Martin, Julia Pomoransky, Caroline J. Breitbach, Jonathan L. Bramson, John C. Bell, Yonghong Wan, David F. Stojdl, Brian D. Lichty & J. Andrea McCart. (2019) Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials. OncoImmunology 8:1.
Read now
Read now
Katie L. Flanagan & Magdalena Plebanski. (2017) Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited. Expert Review of Vaccines 16:1, pages 5-13.
Read now
Read now
Emily A. Voigt, Richard B. Kennedy & Gregory A. Poland. (2016) Defending against smallpox: a focus on vaccines. Expert Review of Vaccines 15:9, pages 1197-1211.
Read now
Read now
Yongqun He. (2014) Ontology-supported research on vaccine efficacy, safety and integrative biological networks. Expert Review of Vaccines 13:7, pages 825-841.
Read now
Read now
Annacarmen Petrizzo, Maria Tagliamonte, Marialina Tornesello, Franco M Buonaguro & Luigi Buonaguro. (2014) Systems vaccinology for cancer vaccine development. Expert Review of Vaccines 13:6, pages 711-719.
Read now
Read now
Richard B Kennedy, Inna G Ovsyannikova, Nathaniel D Lambert, Iana H Haralambieva & Gregory A Poland. (2014) The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Review of Vaccines 13:5, pages 657-669.
Read now
Read now
Robert Ball. (2014) Perspectives on the future of postmarket vaccine safety surveillance and evaluation. Expert Review of Vaccines 13:4, pages 455-462.
Read now
Read now
Adrian Bot, Francesco Marincola & Kent A Smith. (2013) Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions. Expert Review of Vaccines 12:10, pages 1219-1234.
Read now
Read now
Adrian Reber & Jacqueline Katz. (2013) Immunological assessment of influenza vaccines and immune correlates of protection. Expert Review of Vaccines 12:5, pages 519-536.
Read now
Read now
Gillian Bartlett, Jumana Antoun & Nathalie K Zgheib. (2012) Theranostics in primary care: pharmacogenomics tests and beyond. Expert Review of Molecular Diagnostics 12:8, pages 841-855.
Read now
Read now
Ger T Rijkers, Suzan P van Mens & Heleen van Velzen-Blad. (2010) What do the next 100 years hold for pneumococcal vaccination?. Expert Review of Vaccines 9:11, pages 1241-1244.
Read now
Read now
Neelam Dhiman, David I Smith & Gregory A Poland. (2009) Next-generation sequencing: a transformative tool for vaccinology. Expert Review of Vaccines 8:8, pages 963-967.
Read now
Read now
Articles from other publishers (100)
Priyanka, Mai Abdel Haleem Abusalah, Hitesh Chopra, Abhilasha Sharma, Suhad Asad Mustafa, Om Prakash Choudhary, Manish Sharma, Manish Dhawan, Rajiv Khosla, Aanchal Loshali, Ankush Sundriyal & Jyoti Saini. (2023) Nanovaccines: A game changing approach in the fight against infectious diseases. Biomedicine & Pharmacotherapy 167, pages 115597.
Crossref
Crossref
Ruth A. Purcell, Robert M. Theisen, Kelly B. Arnold, Amy W. Chung & Kevin J. Selva. (2023) Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations. Frontiers in Immunology 14.
Crossref
Crossref
Nicola Lott, Caroline E. Gebhard, Susan Bengs, Ahmed Haider, Gabriela M. Kuster, Vera Regitz-Zagrosek & Catherine Gebhard. (2022) Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?. Nature Reviews Endocrinology 19:4, pages 217-231.
Crossref
Crossref
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, Shokouh Rezaei, Vuk Uskoković, Mahdi Alijanianzadeh, Vladimir N. Uversky, Seyed Omid Ranaei Siadat, Sina Mozaffari-Jovin & Yahya Sefidbakht. (2023) An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines. Progress in Biophysics and Molecular Biology 178, pages 32-49.
Crossref
Crossref
Meredith Leston, Simon de Lusignan & F D Richard Hobbs. (2023) A targeted approach to vaccine hesitancy. Oxford Open Immunology 4:1.
Crossref
Crossref
Dragan Trivanović, Željka Peršurić, Andrea Agaj, Marko Jakopović, Miroslav Samaržija, Lela Bitar & Krešimir Pavelić. (2022) The Interplay of Lung Cancer, COVID-19, and Vaccines. International Journal of Molecular Sciences 23:23, pages 15067.
Crossref
Crossref
Rafał Jabłuszewski & Agnieszka Wyszyńska. (2022) Współczesne Metody Identyfikacji Białkowych Antygenów Szczepionkowych. Postępy Mikrobiologii - Advancements of Microbiology 61:4, pages 211-221.
Crossref
Crossref
Rana Hijazi, Anat Gesser-Edelsburg, Paula Feder-Bubis & Gustavo S. Mesch. (2022) Hesitant and anti-vaccination groups: A qualitative study on their perceptions and attitudes regarding vaccinations and their reluctance to participate in academic research- an example during a measles outbreak among a group of Jewish parents in Israel. Frontiers in Public Health 10.
Crossref
Crossref
Benjamin D. Brooks, Alexander Beland, Gabriel Aguero, Nicholas Taylor & Francina D. Towne. (2022) Moving beyond Titers. Vaccines 10:5, pages 683.
Crossref
Crossref
Attya Bhatti, Ayesha Rehman & Peter John. 2022. Biotechnology in Healthcare. Biotechnology in Healthcare
321
342
.
Tanja Opriessnig, Ashley A. Mattei, Anbu K. Karuppannan & Patrick G. Halbur. (2021) Future perspectives on swine viral vaccines: where are we headed?. Porcine Health Management 7:1.
Crossref
Crossref
Melina Farshbafnadi, Sara Kamali Zonouzi, Mohammadmahdi Sabahi, Mahsa Dolatshahi & Mohammad Hadi Aarabi. (2021) Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors. Experimental Gerontology 154, pages 111507.
Crossref
Crossref
Lucille Adam, Pierre Rosenbaum, Olivia Bonduelle & Behazine Combadière. (2021) Strategies for Immunomonitoring after Vaccination and during Infection. Vaccines 9:4, pages 365.
Crossref
Crossref
Jiangan Xie, Wenrui Zi, Zhangyong Li & Yongqun He. (2021) Ontology-based Precision Vaccinology for Deep Mechanism Understanding and Precision Vaccine Development. Current Pharmaceutical Design 27:7, pages 900-910.
Crossref
Crossref
Catherine Gebhard, Vera Regitz-Zagrosek, Hannelore K. Neuhauser, Rosemary Morgan & Sabra L. Klein. (2020) Impact of sex and gender on COVID-19 outcomes in Europe. Biology of Sex Differences 11:1.
Crossref
Crossref
Sarah M Bartsch, Elizabeth A Mitgang, Gail Geller, Sarah N Cox, Kelly J O’Shea, Angie Boyce, Sheryl S Siegmund, Jeffrey Kahn & Bruce Y Lee. (2020) What If the Influenza Vaccine Did Not Offer Such Variable Protection?. The Journal of Infectious Diseases 222:7, pages 1138-1144.
Crossref
Crossref
Peter Piot, Heidi J. Larson, Katherine L. O’Brien, John N’kengasong, Edmond Ng, Samba Sow & Beate Kampmann. (2019) Immunization: vital progress, unfinished agenda. Nature 575:7781, pages 119-129.
Crossref
Crossref
Jong-Myon Bae. (2019) Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea. Journal of Preventive Medicine and Public Health 52:5, pages 277-280.
Crossref
Crossref
Stephen N. Crooke, Iana H. Haralambieva, Diane E. Grill, Inna G. Ovsyannikova, Richard B. Kennedy & Gregory A. Poland. (2019) Seroprevalence and durability of rubella virus antibodies in a highly immunized population. Vaccine 37:29, pages 3876-3882.
Crossref
Crossref
Stephanie Fischinger, Carolyn M. Boudreau, Audrey L. Butler, Hendrik Streeck & Galit Alter. (2018) Sex differences in vaccine-induced humoral immunity. Seminars in Immunopathology 41:2, pages 239-249.
Crossref
Crossref
Katja Fink. (2019) Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence?. Frontiers in Immunology 10.
Crossref
Crossref
Li C. Chong & Asif M. Khan. 2019. Encyclopedia of Bioinformatics and Computational Biology. Encyclopedia of Bioinformatics and Computational Biology
241
251
.
Claudia Ferlito, Roberto Biselli, Sabrina Mariotti, Christina von Hunolstein, Raffaela Teloni, Luisa Ralli, Antonella Pinto, Giulio Pisani, Valentina Tirelli, Michela Ileen Biondo, Gerardo Salerno, Livia Andreasi Bassi, Patrizia Lulli, Alberto Autore, Alessandro Scagliusi, Enrico Tomao, Valentina Germano, Andrea Picchianti Diamanti, Sara Caporuscio, Francesca Milanetti, Simonetta Salemi, Roberto Nisini & Raffaele D'Amelio. (2018) Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1∗01. Vaccine 36:45, pages 6718-6725.
Crossref
Crossref
Minying Zhang, Jens Fritsche, Jason Roszik, Leila J. Williams, Xinxin Peng, Yulun Chiu, Chih-Chiang Tsou, Franziska Hoffgaard, Valentina Goldfinger, Oliver Schoor, Amjad Talukder, Marie A. Forget, Cara Haymaker, Chantale Bernatchez, Leng Han, Yiu-Huen Tsang, Kathleen Kong, Xiaoyan Xu, Kenneth L. Scott, Harpreet Singh-Jasuja, Greg Lizee, Han Liang, Toni Weinschenk, Gordon B. Mills & Patrick Hwu. (2018) RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nature Communications 9:1.
Crossref
Crossref
G.A. Poland, I.G. Ovsyannikova & R.B. Kennedy. (2018) Personalized vaccinology: A review. Vaccine 36:36, pages 5350-5357.
Crossref
Crossref
Maria Vadalà, Dimitri Poddighe, Carmen Laurino & Beniamino Palmieri. (2017) Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?. EPMA Journal 8:3, pages 295-311.
Crossref
Crossref
María Isidoro-García, Almudena Sánchez-Martín, Asunción García-Sánchez, Catalina Sanz, Belén García-Berrocal & Ignacio Dávila. (2017) Pharmacogenetics and the treatment of asthma. Pharmacogenomics 18:13, pages 1271-1280.
Crossref
Crossref
Ranjith Kumavath. (2017) Vaccination to Combat as an Approach to Reduce the Antibacterial Resistance..!. International Journal of Vaccines & Vaccination 4:1.
Crossref
Crossref
Gary Wagman. (2017) Sasang Medical Perspectives on Viral Immunity: A Discussion of Intrinsic, Constitutionally Related Factors in Disease Onset and Resistance. Journal of Acupuncture and Meridian Studies 10:1, pages 1-4.
Crossref
Crossref
Emily A. Voigt, Inna G. Ovsyannikova, Iana H. Haralambieva, Richard B. Kennedy, Beth R. Larrabee, Daniel J. Schaid & Gregory A. Poland. (2016) Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination. Vaccine 34:41, pages 4913-4919.
Crossref
Crossref
Gregory A Poland, Jennifer A Whitaker, Caroline M Poland, Inna G Ovsyannikova & Richard B Kennedy. (2016) Vaccinology in the third millennium: scientific and social challenges. Current Opinion in Virology 17, pages 116-125.
Crossref
Crossref
P Pellegrino, F S Falvella, S Cheli, C Perrotta, E Clementi & S Radice. (2015) The role of Toll-like receptor 4 polymorphisms in vaccine immune response. The Pharmacogenomics Journal 16:1, pages 96-101.
Crossref
Crossref
Apostolos P. Georgopoulos, Lisa M. James, Margaret Y. Mahan, Jasmine Joseph, Angeliki Georgopoulos & Brian E. Engdahl. (2016) Reduced Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI). EBioMedicine 3, pages 79-85.
Crossref
Crossref
Michael O. S. Afolabi. 2016. Encyclopedia of Global Bioethics. Encyclopedia of Global Bioethics
2911
2918
.
Ashley L. Fink & Sabra L. Klein. (2015) Sex and Gender Impact Immune Responses to Vaccines Among the Elderly. Physiology 30:6, pages 408-416.
Crossref
Crossref
Jesse D. Troy, Heather R. Hill, Marian G. Ewell & Sharon E. Frey. (2015) Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE ® smallpox vaccine. Vaccine 33:41, pages 5425-5431.
Crossref
Crossref
Ann L. Oberg, Brett A. McKinney, Daniel J. Schaid, V. Shane Pankratz, Richard B. Kennedy & Gregory A. Poland. (2015) Lessons learned in the analysis of high-dimensional data in vaccinomics. Vaccine 33:40, pages 5262-5270.
Crossref
Crossref
Catherine Laughlin, Amanda Schleif & Carole A Heilman. (2015) Addressing viral resistance through vaccines. Future Virology 10:8, pages 1011-1022.
Crossref
Crossref
Nishita Vaishnav, Aparna Gupta, Sneha Paul & Georrge J. John. (2014) Overview of computational vaccinology: vaccine development through information technology. Journal of Applied Genetics 56:3, pages 381-391.
Crossref
Crossref
John Castiblanco & Juan-Manuel Anaya. 2015. Vaccines and Autoimmunity. Vaccines and Autoimmunity
65
78
.
Alexander J. Mentzer, Daniel O'Connor, Andrew J. Pollard & Adrian V. S. Hill. (2015) Searching for the human genetic factors standing in the way of universally effective vaccines. Philosophical Transactions of the Royal Society B: Biological Sciences 370:1671, pages 20140341.
Crossref
Crossref
Michael Olusegun Afolabi. 2014. Encyclopedia of Global Bioethics. Encyclopedia of Global Bioethics
1
9
.
Lori Garman, Amanda J. Vineyard, Sherry R. Crowe, John B. Harley, Christina E. Spooner, Limone C. Collins, Michael R. Nelson, Renata J.M. Engler & Judith A. James. (2014) Humoral responses to independent vaccinations are correlated in healthy boosted adults. Vaccine 32:43, pages 5624-5631.
Crossref
Crossref
P. Pellegrino, E. Clementi & S. Radice. (2014) Re: "Postelimination Transmission of Measles in the US". American Journal of Epidemiology 180:4, pages 452-452.
Crossref
Crossref
Inna G. Ovsyannikova, V. Shane Pankratz, Beth R. Larrabee, Robert M. Jacobson & Gregory A. Poland. (2014) HLA genotypes and rubella vaccine immune response: Additional evidence. Vaccine 32:33, pages 4206-4213.
Crossref
Crossref
Yu Lin & Yongqun He. (2014) The ontology of genetic susceptibility factors (OGSF) and its application in modeling genetic susceptibility to vaccine adverse events. Journal of Biomedical Semantics 5:1, pages 19.
Crossref
Crossref
H. D. Clifford, C. M. Hayden, S.-K. Khoo, D. Naniche, I. M. Mandomando, G. Zhang, P. Richmond & P. N. Le Souëf. (2013)
Impact of
CD14
promoter variants on measles vaccine responses and vaccine failure in children from Australia and Mozambique
. Tissue Antigens 82:6, pages 420-422.
Crossref
Crossref
Mona Al-Dabbagh, Keswadee Lapphra, David W. Scheifele, Scott A. Halperin, Joanne M. Langley, Patricia Cho, Tobias R. Kollmann, Yan Li, Gaston De Serres, Edgardo S. FortunoIIIIII & Julie A. Bettinger. (2013) Elevated Inflammatory Mediators in Adults with Oculorespiratory Syndrome following Influenza Immunization: a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study. Clinical and Vaccine Immunology 20:8, pages 1108-1114.
Crossref
Crossref
R B Kennedy, A L Oberg, I G Ovsyannikova, I H Haralambieva, D Grill & G A Poland. (2013) Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes & Immunity 14:5, pages 277-285.
Crossref
Crossref
Sabra L. Klein & Gregory A. Poland. (2013) Personalized vaccinology: One size and dose might not fit both sexes. Vaccine 31:23, pages 2599-2600.
Crossref
Crossref
Gregory A. Poland, Richard B. Kennedy, Brett A. McKinney, Inna G. Ovsyannikova, Nathaniel D. Lambert, Robert M. Jacobson & Ann L. Oberg. (2013) Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century. Seminars in Immunology 25:2, pages 89-103.
Crossref
Crossref
Patricio A. Manque & Ute Woehlbier. 2013. Data Mining. Data Mining
1131
1148
.
P. Prachi, C. Donati, F. Masciopinto, R. Rappuoli & F. Bagnoli. (2013) Deep Sequencing in Pre- and Clinical Vaccine Research. Public Health Genomics 16:1-2, pages 62-68.
Crossref
Crossref
Carolyn M. Gallagher, Dylan M. Smith, Marc G. Golightly & Jaymie R. Meliker. (2013) Total blood mercury and rubella antibody concentrations in US children aged 6–11years, NHANES 2003–2004. Science of The Total Environment 442, pages 48-55.
Crossref
Crossref
Eun Hwa Choi, Hoan Jong Lee & Stephen J. Chanock. 2013. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
121
137
.
Sabra L. Klein. 2012. Sex and Gender Differences in Pharmacology. Sex and Gender Differences in Pharmacology
499
522
.
Bertrand Bellier, Adrien Six, Véronique Thomas-Vaslin & David Klatzmann. 2013. Encyclopedia of Systems Biology. Encyclopedia of Systems Biology
2335
2336
.
Sabra L. Klein. (2012) Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. BioEssays 34:12, pages 1050-1059.
Crossref
Crossref
Farah Huzair & Alexander Borda-Rodriguez. (2012) Challenges for the Application and Development of Omics Health Technologies in Developing Countries. Drug Development Research 73:7, pages 447-451.
Crossref
Crossref
Holly D. Clifford, Catherine M. Hayden, Siew-Kim Khoo, Denise Naniche, Inacio M. Mandomando, Guicheng Zhang, Peter Richmond & Peter N. Le Souëf. (2012) Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Vaccine 30:43, pages 6180-6185.
Crossref
Crossref
Wang Yuanqiang, Cai Jiali, Lin Zhihua & Xia Qingyou. (2012) QSAR modeling of human TAP-binding peptide based on amino acid properties. QSAR modeling of human TAP-binding peptide based on amino acid properties.
José Tuells. (2012) Vaccinology: The name, the concept, the adjectives. Vaccine 30:37, pages 5491-5495.
Crossref
Crossref
Sabra L. Klein. (2012) Immune Cells Have Sex and So Should Journal Articles. Endocrinology 153:6, pages 2544-2550.
Crossref
Crossref
Holly D. Clifford, Stephanie T. Yerkovich, Siew-Kim Khoo, Guicheng Zhang, John Upham, Peter N. Le Souëf, Peter Richmond & Catherine M. Hayden. (2012) TLR3 and RIG-I gene variants: Associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants. Human Immunology 73:6, pages 677-685.
Crossref
Crossref
Kewal K. Jain. 2012. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
553
580
.
Jaythoon Hassan, Jonathan Dean, Eibhlín Moss, Michael J. Carr, William W. Hall & Jeff Connell. (2012) Seroepidemiology of the recent mumps virus outbreaks in Ireland. Journal of Clinical Virology 53:4, pages 320-324.
Crossref
Crossref
Ger T RijkersGer T Rijkers. 2012. Pneumococcal Conjugate Vaccines. Pneumococcal Conjugate Vaccines
2
7
.
Ger T Rijkers. 2012. Pneumococcal Conjugate Vaccines. Pneumococcal Conjugate Vaccines.
Adrien Six, Bertrand Bellier, Véronique Thomas-Vaslin & David Klatzmann. (2012) Systems biology in vaccine design. Microbial Biotechnology 5:2, pages 295-304.
Crossref
Crossref
Inna G. Ovsyannikova, V. Shane Pankratz, Robert A. Vierkant, Robert M. Jacobson & Gregory A. Poland. (2012) Consistency of HLA associations between two independent measles vaccine cohorts: A replication study. Vaccine 30:12, pages 2146-2152.
Crossref
Crossref
Christi Baker & Janis Antonovics. (2012) Evolutionary Determinants of Genetic Variation in Susceptibility to Infectious Diseases in Humans. PLoS ONE 7:1, pages e29089.
Crossref
Crossref
Yo Han JangBaik-Lin Seong. (2012) Principles underlying rational design of live attenuated influenza vaccines. Clinical and Experimental Vaccine Research 1:1, pages 35.
Crossref
Crossref
Gregory A. Poland, Richard B. Kennedy & Inna G. Ovsyannikova. (2011) Vaccinomics and Personalized Vaccinology: Is Science Leading Us Toward a New Path of Directed Vaccine Development and Discovery?. PLoS Pathogens 7:12, pages e1002344.
Crossref
Crossref
Monika Adamczyk-Poplawska, Sergiusz Markowicz & Elzbieta K. Jagusztyn-Krynicka. (2011) Proteomics for development of vaccine. Journal of Proteomics 74:12, pages 2596-2616.
Crossref
Crossref
Robert M. Jacobson, Inna G. Ovsyannikova, Robert A. Vierkant, V. Shane Pankratz & Gregory A. Poland. (2011) Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: Persistence, dampening, and extinction of associations found after a first dose. Vaccine 29:45, pages 7982-7991.
Crossref
Crossref
Inna G. Ovsyannikova & Gregory A. Poland. (2011) Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development. The AAPS Journal 13:3, pages 438-444.
Crossref
Crossref
Gregory A. PolandInna G. OvsyannikovaRichard B. KennedyIana H. HaralambievaRobert M. Jacobson. (2011) Vaccinomics and a New Paradigm for the Development of Preventive Vaccines Against Viral Infections. OMICS: A Journal of Integrative Biology 15:9, pages 625-636.
Crossref
Crossref
Richard B. KennedyGregory A. Poland. (2011) The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development. OMICS: A Journal of Integrative Biology 15:9, pages 533-537.
Crossref
Crossref
Megan M. O'MearaMary L. Disis. (2011) Therapeutic Cancer Vaccines and Translating Vaccinomics Science to the Global Health Clinic: Emerging Applications Toward Proof of Concept. OMICS: A Journal of Integrative Biology 15:9, pages 579-588.
Crossref
Crossref
Tiruvayipati Suma AvasthiNiyaz Ahmed. (2011)
Helicobacter pylori
and Type 1 Diabetes Mellitus: Possibility of Modifying Chronic Disease Susceptibility with Vaccinomics at the Anvil
. OMICS: A Journal of Integrative Biology 15:9, pages 589-596.
Crossref
Crossref
Ma'n H. ZawatiMatthew HendyYann Joly. (2011) Incidental Findings in Data-Intensive Postgenomics Science and Legal Liability of Clinician–Researchers: Ready for Vaccinomics?. OMICS: A Journal of Integrative Biology 15:9, pages 615-624.
Crossref
Crossref
Yann JolyGeorgia KoutrikasEmma Ramos-PaqueMa'n ZawatiJennifer GardyMichael R. HaydenBruce C. Carleton. (2011) Diagnostic Testing for Vaccinomics: Is the Regulatory Approval Framework Adequate? A Comparison of Canada, the United States, and Europe. OMICS: A Journal of Integrative Biology 15:9, pages 597-605.
Crossref
Crossref
Fabio BagnoliBarbara BaudnerRavi P.N. MishraErika BartoliniLuigi FiaschiPaolo MariottiVincenzo Nardi-DeiPhil BoucherRino Rappuoli. (2011) Designing the Next Generation of Vaccines for Global Public Health. OMICS: A Journal of Integrative Biology 15:9, pages 545-566.
Crossref
Crossref
Britta Denman & Steven R Goodman. (2011) Emerging and neglected tropical diseases: translational application of proteomics. Experimental Biology and Medicine 236:8, pages 972-976.
Crossref
Crossref
Maryam Amidi, Markus de Raad, Daan J. A. Crommelin, Wim E. Hennink & Enrico Mastrobattista. (2010) Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine. Systems and Synthetic Biology 5:1-2, pages 21-31.
Crossref
Crossref
Patricio A. Manque & Ute Woehlbier. 2011. Handbook of Research on Computational and Systems Biology. Handbook of Research on Computational and Systems Biology
61
78
.
V Chatzidaki, E Kouroumalis & E Galanakis. (2011) Hepatitis B Virus Acquisition and Pathogenesis in Childhood: Host Genetic Determinants. Journal of Pediatric Gastroenterology & Nutrition 52:1, pages 3-8.
Crossref
Crossref
Grzegorz A. Rempala, MichaŁ Seweryn & Leszek Ignatowicz. (2011) Model for comparative analysis of antigen receptor repertoires. Journal of Theoretical Biology 269:1, pages 1-15.
Crossref
Crossref
Inna G. Ovsyannikova, Robert A. Vierkant, V. Shane Pankratz, Robert M. Jacobson & Gregory A. Poland. (2010) Extended LTA, TNF, LST1 and HLA Gene Haplotypes and Their Association with Rubella Vaccine-Induced Immunity. PLoS ONE 5:7, pages e11806.
Crossref
Crossref
Scott McVey & Jishu Shi. (2010) Vaccines in Veterinary Medicine: A Brief Review of History and Technology. Veterinary Clinics of North America: Small Animal Practice 40:3, pages 381-392.
Crossref
Crossref
Sabra L Klein, Anne Jedlicka & Andrew Pekosz. (2010) The Xs and Y of immune responses to viral vaccines. The Lancet Infectious Diseases 10:5, pages 338-349.
Crossref
Crossref
Gregory A. Poland & Ann L. Oberg. (2010) Vaccinomics and bioinformatics: Accelerants for the next golden age of vaccinology. Vaccine 28:20, pages 3509-3510.
Crossref
Crossref
Gavin C. Bowick & Alan D. T. Barrett. (2010) Comparative Pathogenesis and Systems Biology for Biodefense Virus Vaccine Development. Journal of Biomedicine and Biotechnology 2010, pages 1-11.
Crossref
Crossref
Yongqun He, Rino Rappuoli, Anne S. De Groot & Robert T. Chen. (2010) Emerging Vaccine Informatics. Journal of Biomedicine and Biotechnology 2010, pages 1-26.
Crossref
Crossref
Inna G. Ovsyannikova, Robert M. Jacobson, Robert A. Vierkant, Megan M. O’Byrne & Gregory A. Poland. (2009) Replication of rubella vaccine population genetic studies: Validation of HLA genotype and humoral response associations. Vaccine 27:49, pages 6926-6931.
Crossref
Crossref
C. Daniela Rinaudo, John L. Telford, Rino Rappuoli & Kate L. Seib. (2009) Vaccinology in the genome era. Journal of Clinical Investigation 119:9, pages 2515-2525.
Crossref
Crossref
Gregory A Poland, Inna G Ovsyannikova & Robert M Jacobson. (2009) Application of pharmacogenomics to vaccines. Pharmacogenomics 10:5, pages 837-852.
Crossref
Crossref
Inna G. Ovsyannikova, Robert A. Vierkant, V. Shane Pankratz, Megan M. O’Byrne, Robert M. Jacobson & Gregory A. Poland. (2009) HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine. Vaccine 27:25-26, pages 3349-3358.
Crossref
Crossref
Vural OzdemirGuilherme Suarez-KurtzRaphaëlle StenneAndrew A. SomogyiToshiyuki SomeyaS. Oğuz KayaalpEugene Kolker. (2009) Risk Assessment and Communication Tools for Genotype Associations with Multifactorial Phenotypes: The Concept of “Edge Effect” and Cultivating an Ethical Bridge between Omics Innovations and Society. OMICS: A Journal of Integrative Biology 13:1, pages 43-61.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2009. Textbook of Personalized Medicine. Textbook of Personalized Medicine
137
147
.